{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:41:54Z","timestamp":1792428114709,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.leukres.2026.108321","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:36:10Z","timestamp":1789688170000},"page":"108321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The diagnostic utility of the soluble CD25-to-ferritin ratio in lymphoma-associated hemophagocytic lymphohistiocytosis"],"prefix":"10.1016","volume":"170","author":[{"given":"Dariusz","family":"Uczkowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5515-5515","authenticated-orcid":false,"given":"Linzi M.","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9108-177X","authenticated-orcid":false,"given":"Stephanie","family":"Yohay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adarsh","family":"Ettyreddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Gontarczyk","family":"Uczkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4542-4232","authenticated-orcid":false,"given":"Chenyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3563-5236","authenticated-orcid":false,"given":"Alexander","family":"Coltoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C.","family":"Michaelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa Baumann","family":"Kreuziger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirav N.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehab","family":"Atallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2026.108321_bib1","first-page":"697","article-title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","volume":"94","author":"La Ros\u00e9e","year":"2019","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2026.108321_bib2","first-page":"267","article-title":"How I treat hemophagocytic lymphohistiocytosis in the adult patient","volume":"90","author":"Schram","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2026.108321_bib3","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2026.108321_bib4","first-page":"e150","article-title":"Adult haemophagocytic syndrome","volume":"1","author":"Ramos-Casals","year":"2014","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.leukres.2026.108321_bib5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajh.23911","article-title":"Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis","volume":"90","author":"Otrock","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2026.108321_bib6","first-page":"761","article-title":"Haemophagocytic lymphohistiocytosis in adults: a multicenter case series over 7 years","volume":"91","author":"Schram","year":"2016","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2026.108321_bib7","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1080\/10428194.2024.2436037","article-title":"Malignancy-associated HLH: mechanisms, diagnosis, and treatment of a severe hyperinflammatory syndrome","volume":"66","author":"Zoref-Lorenz","year":"2025","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.leukres.2026.108321_bib8","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1182\/bloodadvances.2017012310","article-title":"Soluble interleukin-2 receptor is a sensitive diagnostic test in adult HLH","volume":"1","author":"Hayden","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.leukres.2026.108321_bib9","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00277-017-2993-y","article-title":"Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review","volume":"96","author":"Lin","year":"2017","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2026.108321_bib10","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2014-10-602607","article-title":"Marked hyperferritinemia does not predict for HLH in the adult population","volume":"125","author":"Schram","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2026.108321_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00277-011-1239-7","article-title":"Possible prediction of underlying lymphoma by high sIL-2R\/ferritin ratio in hemophagocytic syndrome","volume":"91","author":"Tabata","year":"2012","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2026.108321_bib12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00277-013-1925-8","article-title":"A high sIL-2R\/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome","volume":"93","author":"Tsuji","year":"2014","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2026.108321_bib13","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1080\/10428194.2016.1195498","article-title":"The SIL index is a simple and objective prognostic indicator in diffuse large B-cell lymphoma","volume":"57","author":"Tomita","year":"2016","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.leukres.2026.108321_bib14","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s12185-009-0304-7","article-title":"Intravascular large B cell lymphoma: proposal of a strategy for early diagnosis and treatment of patients with rapidly deteriorating condition","volume":"89","author":"Masaki","year":"2009","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.leukres.2026.108321_bib15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.leukres.2026.108321_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1182\/blood.2023022062","article-title":"Just in time: mal-HLH in Sweden, 1997\u20132018","volume":"143","author":"Martin","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2026.108321_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jaci.2025.09.005","article-title":"The diagnostic pitfall of sIL-2R in hemophagocytic lymphohistiocytosis: a key marker lost in analytic translation","volume":"157","author":"Fauser","year":"2026","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.leukres.2026.108321_bib18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/1744666X.2026.2637765","article-title":"Validation of a rapid fluorescence immunoassay for soluble interleukin-2 receptor alpha in a pediatric population","volume":"22","author":"Logan","year":"2026","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.leukres.2026.108321_bib19","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1182\/blood.2021012764","article-title":"An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis","volume":"139","author":"Zoref-Lorenz","year":"2022","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626001657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626001657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:07:28Z","timestamp":1792426048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212626001657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":19,"alternative-id":["S0145212626001657"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108321","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The diagnostic utility of the soluble CD25-to-ferritin ratio in lymphoma-associated hemophagocytic lymphohistiocytosis","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108321"}}